Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer
Stopped drug supply issues
Conditions
- Colon Adenocarcinoma
- Metastatic Pancreatic Adenocarcinoma
- Pancreatic Adenocarcinoma
- Pancreatic Ductal Adenocarcinoma
- Rectal Adenocarcinoma
- Stage III Pancreatic Cancer
- Stage IIIA Colon Cancer
- Stage IIIA Rectal Cancer
- Stage IIIB Colon Cancer
- Stage IIIB Rectal Cancer
- Stage IIIC Colon Cancer
- Stage IIIC Rectal Cancer
- Stage IV Pancreatic Cancer
- Stage IVA Colon Cancer
- Stage IVA Rectal Cancer
- Stage IVB Colon Cancer
- Stage IVB Rectal Cancer
Interventions
- DRUG: Fluorouracil
- DRUG: Irinotecan Hydrochloride
- OTHER: Laboratory Biomarker Analysis
- DRUG: Oxaliplatin
- DRUG: pan FGFR Kinase Inhibitor BGJ398
- OTHER: Pharmacological Study
Sponsor
Roswell Park Cancer Institute
Collaborators